Go Pro

Clover Health Investments (CLOV) Competitors

Clover Health Investments logo
$4.17 -0.17 (-3.92%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$4.19 +0.02 (+0.55%)
As of 07/31/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CLOV vs. VOYA, OSCR, JXN, KNSL, and ACT

Should you buy Clover Health Investments stock or one of its competitors? MarketBeat compares Clover Health Investments with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Clover Health Investments include Voya Financial (VOYA), Oscar Health (OSCR), Jackson Financial (JXN), Kinsale Capital Group (KNSL), and Enact (ACT).

How does Clover Health Investments compare to Voya Financial?

Voya Financial (NYSE:VOYA) and Clover Health Investments (NASDAQ:CLOV) are related mid-cap companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation and profitability.

Voya Financial has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Voya Financial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Voya Financial$8.19B1.10$654M$6.6215.04
Clover Health Investments$1.92B1.14-$85.55M-$0.12N/A

In the previous week, Voya Financial had 6 more articles in the media than Clover Health Investments. MarketBeat recorded 9 mentions for Voya Financial and 3 mentions for Clover Health Investments. Voya Financial's average media sentiment score of 1.00 beat Clover Health Investments' score of 0.54 indicating that Voya Financial is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Voya Financial
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Clover Health Investments
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Voya Financial has a net margin of 8.24% compared to Clover Health Investments' net margin of -2.58%. Voya Financial's return on equity of 13.84% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Voya Financial8.24% 13.84% 0.52%
Clover Health Investments -2.58%-16.52%-9.28%

96.1% of Voya Financial shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 1.6% of Voya Financial shares are held by company insiders. Comparatively, 23.5% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Voya Financial has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.48, suggesting that its stock price is 148% more volatile than the broader market.

Voya Financial presently has a consensus target price of $100.15, indicating a potential upside of 0.62%. Clover Health Investments has a consensus target price of $4.25, indicating a potential upside of 1.92%. Given Clover Health Investments' higher possible upside, analysts clearly believe Clover Health Investments is more favorable than Voya Financial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Voya Financial
1 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.69
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Voya Financial beats Clover Health Investments on 13 of the 17 factors compared between the two stocks.

How does Clover Health Investments compare to Oscar Health?

Oscar Health (NYSE:OSCR) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

In the previous week, Oscar Health had 3 more articles in the media than Clover Health Investments. MarketBeat recorded 6 mentions for Oscar Health and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.54 beat Oscar Health's score of 0.43 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Clover Health Investments
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Oscar Health has a beta of 2.36, indicating that its stock price is 136% more volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.48, indicating that its stock price is 148% more volatile than the broader market.

Oscar Health has a net margin of -0.30% compared to Clover Health Investments' net margin of -2.58%. Oscar Health's return on equity of -3.26% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health-0.30% -3.26% -0.57%
Clover Health Investments -2.58%-16.52%-9.28%

Oscar Health presently has a consensus target price of $22.00, indicating a potential downside of 29.79%. Clover Health Investments has a consensus target price of $4.25, indicating a potential upside of 1.92%. Given Clover Health Investments' higher probable upside, analysts clearly believe Clover Health Investments is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
1 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.33
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 22.6% of Oscar Health shares are owned by insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Clover Health Investments has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.81-$443.15M-$0.59N/A
Clover Health Investments$1.92B1.14-$85.55M-$0.12N/A

Summary

Oscar Health beats Clover Health Investments on 9 of the 17 factors compared between the two stocks.

How does Clover Health Investments compare to Jackson Financial?

Jackson Financial (NYSE:JXN) and Clover Health Investments (NASDAQ:CLOV) are related mid-cap companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability and earnings.

Jackson Financial has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Jackson Financial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jackson Financial$6.68B1.28$27M-$6.11N/A
Clover Health Investments$1.92B1.14-$85.55M-$0.12N/A

Jackson Financial presently has a consensus target price of $126.40, suggesting a potential upside of 3.43%. Clover Health Investments has a consensus target price of $4.25, suggesting a potential upside of 1.92%. Given Jackson Financial's stronger consensus rating and higher possible upside, research analysts plainly believe Jackson Financial is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jackson Financial
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.57
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Jackson Financial has a net margin of 0.00% compared to Clover Health Investments' net margin of -2.58%. Jackson Financial's return on equity of 17.21% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Jackson FinancialN/A 17.21% 0.49%
Clover Health Investments -2.58%-16.52%-9.28%

Jackson Financial has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.48, indicating that its share price is 148% more volatile than the broader market.

90.0% of Jackson Financial shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 1.4% of Jackson Financial shares are owned by company insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Jackson Financial had 7 more articles in the media than Clover Health Investments. MarketBeat recorded 10 mentions for Jackson Financial and 3 mentions for Clover Health Investments. Jackson Financial's average media sentiment score of 1.51 beat Clover Health Investments' score of 0.54 indicating that Jackson Financial is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jackson Financial
9 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Clover Health Investments
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Jackson Financial beats Clover Health Investments on 14 of the 17 factors compared between the two stocks.

How does Clover Health Investments compare to Kinsale Capital Group?

Clover Health Investments (NASDAQ:CLOV) and Kinsale Capital Group (NYSE:KNSL) are related mid-cap companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Kinsale Capital Group has a net margin of 28.49% compared to Clover Health Investments' net margin of -2.58%. Kinsale Capital Group's return on equity of 25.54% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-2.58% -16.52% -9.28%
Kinsale Capital Group 28.49%25.54%8.15%

Clover Health Investments has a beta of 2.48, indicating that its stock price is 148% more volatile than the broader market. Comparatively, Kinsale Capital Group has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market.

19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 85.4% of Kinsale Capital Group shares are owned by institutional investors. 23.5% of Clover Health Investments shares are owned by insiders. Comparatively, 5.6% of Kinsale Capital Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Kinsale Capital Group had 17 more articles in the media than Clover Health Investments. MarketBeat recorded 20 mentions for Kinsale Capital Group and 3 mentions for Clover Health Investments. Kinsale Capital Group's average media sentiment score of 1.07 beat Clover Health Investments' score of 0.54 indicating that Kinsale Capital Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kinsale Capital Group
11 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Clover Health Investments presently has a consensus target price of $4.25, suggesting a potential upside of 1.92%. Kinsale Capital Group has a consensus target price of $362.11, suggesting a potential upside of 1.24%. Given Clover Health Investments' stronger consensus rating and higher probable upside, equities analysts plainly believe Clover Health Investments is more favorable than Kinsale Capital Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Kinsale Capital Group
3 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.80

Kinsale Capital Group has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Kinsale Capital Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.14-$85.55M-$0.12N/A
Kinsale Capital Group$2.00B4.08$503.61M$24.6814.49

Summary

Kinsale Capital Group beats Clover Health Investments on 11 of the 15 factors compared between the two stocks.

How does Clover Health Investments compare to Enact?

Enact (NASDAQ:ACT) and Clover Health Investments (NASDAQ:CLOV) are related mid-cap companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

18.0% of Enact shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 0.6% of Enact shares are owned by insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Clover Health Investments has a consensus price target of $4.25, indicating a potential upside of 1.92%. Given Clover Health Investments' stronger consensus rating and higher probable upside, analysts plainly believe Clover Health Investments is more favorable than Enact.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enact
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Clover Health Investments had 3 more articles in the media than Enact. MarketBeat recorded 3 mentions for Clover Health Investments and 0 mentions for Enact. Enact's average media sentiment score of 1.00 beat Clover Health Investments' score of 0.54 indicating that Enact is being referred to more favorably in the media.

Company Overall Sentiment
Enact Positive
Clover Health Investments Positive

Enact has a beta of 0.49, meaning that its stock price is 51% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.48, meaning that its stock price is 148% more volatile than the broader market.

Enact has a net margin of 54.49% compared to Clover Health Investments' net margin of -2.58%. Enact's return on equity of 13.02% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Enact54.49% 13.02% 10.05%
Clover Health Investments -2.58%-16.52%-9.28%

Enact has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Enact, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enact$1.24B5.35$674.24M$4.6110.26
Clover Health Investments$1.92B1.14-$85.55M-$0.12N/A

Summary

Enact and Clover Health Investments tied by winning 8 of the 16 factors compared between the two stocks.

Get Clover Health Investments News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLOV vs. The Competition

MetricClover Health InvestmentsHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$2.20B$9.87B$7.17B$12.47B
Dividend YieldN/A2.52%2.59%10.03%
P/E Ratio-34.7525.44282.2524.53
Price / Sales1.144.77588.6490.94
Price / CashN/A26.2428.6046.71
Price / Book7.075.1410.936.07
Net Income-$85.55M$311.05M$3.50B$348.34M
7 Day Performance-3.47%-0.29%-0.24%0.09%
1 Month Performance-20.72%-1.50%-3.70%-5.17%
1 Year Performance50.00%26.23%61.98%18.61%

Clover Health Investments Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLOV
Clover Health Investments
0.9397 of 5 stars
$4.17
-3.9%
$4.25
+1.9%
+50.0%$2.20B$1.92BN/A680
VOYA
Voya Financial
4.6899 of 5 stars
$98.96
+0.4%
$100.15
+1.2%
+47.9%$8.94B$8.19B14.9511,000
OSCR
Oscar Health
1.9897 of 5 stars
$28.29
+0.4%
$20.78
-26.6%
+130.7%$8.50B$11.70BN/A2,305
JXN
Jackson Financial
1.7009 of 5 stars
$121.05
+1.5%
$126.40
+4.4%
+45.4%$8.32B$6.68BN/A3,890
KNSL
Kinsale Capital Group
2.6853 of 5 stars
$361.61
+3.6%
$374.90
+3.7%
-19.5%$8.05B$2.00B14.65470

Related Companies and Tools


This page (NASDAQ:CLOV) was last updated on 8/2/2026 by MarketBeat.com Staff.
From Our Partners